insights_auto
Why is CUV down 2.88%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.42
arrow_downward
-2.88%(-0.22) 1D
Nov 13, 4:10:12 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.55
High
A$7.57
Low
A$7.34
Mkt. cap
374.61M
Avg. vol.
157.39K
Volume
78.79K
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.11
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.55
High
A$7.57
Low
A$7.34
Mkt. cap
374.61M
Avg. vol.
157.39K
Volume
78.79K
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.11
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
TradingKey
·
33 minutes ago
Is the US Stock Selloff Over? Wall Street Debates AI Bubble as S&P 500, Chip Stocks Diverge for 2027
www.tokenpost.com
·
1 hour ago
James Wynn Trims 50x S&P 500 Short With 94-Point Liquidation Gap
Traders Union
·
7 hours ago
S&P 500 gains $1.2 trillion in a week, Peter Tuchman notes
qz.com
·
6 hours ago
How much of the S&P 500 is Nvidia? Concentration explained
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com